-
Product Insights
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Drugs In Development, 2024
Empower your strategies with our Adrenocortical Carcinoma (Adrenal Cortex Cancer) – Drugs In Development, 2024 report and make more profitable business decisions. Adrenal cortex cancer (ACC) is a rare disease. It is caused by a cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands. Predisposing factors include female sex, hereditary disease that affects the adrenal glands, age, and smoking. Symptoms include high blood sugar and pressure, muscle weakness in the legs, excessive weight gain in...
-
Product Insights
Pancreatic Tumor - Drugs In Development, 2024
Empower your strategies with our Pancreatic Tumor – Drugs In Development, 2024 report and make more profitable business decisions. Pancreatic cancer refers to the carcinoma arising from the pancreatic duct cells. Small changes in the cellular DNA result in uncontrolled multiplication and accumulation of cells into a tumor. Signs and symptoms of the most common form of pancreatic cancer may include yellow skin, abdominal or back pain, unexplained weight loss, light-colored stools, dark urine, and loss of appetite. Surgical resection is...
-
Product Insights
Hepatobiliary System Tumor - Drugs In Development, 2024
Empower your strategies with our Hepatobiliary System Tumor – Drugs In Development, 2024 report and make more profitable business decisions. A tumor in the hepatobiliary system is a disorder that affects the normal function of the system. The hepatobiliary system includes the liver, gallbladder, and bile ducts The Hepatobiliary System Tumor drugs in development market research report provide comprehensive information on the therapeutics under development for Hepatobiliary System Tumor, complete with analysis by stage of development, drug target, mechanism of action...
-
Product Insights
Mammary Ductal Carcinoma - Drugs In Development, 2024
Empower your strategies with our Mammary Ductal Carcinoma – Drugs In Development, 2024 report and make more profitable business decisions. Ductal carcinoma is a type of breast cancer that occurs in the milk ducts and moves into nearby tissues. There are two types of ductal carcinoma, invasive ductal carcinoma (IDC) and ductal carcinoma in situ (DCIS). If the abnormal cancer cells are seen inside the milk ducts, then it is DCIS. DCIS is also known as intraductal carcinoma or non-invasive ductal...
-
Product Insights
NUT Midline Carcinoma (NMC or Nuclear Protein in Testis Midline Carcinoma) - Drugs In Development, 2024
Empower your strategies with our NUT Midline Carcinoma (NMC or Nuclear Protein in Testis Midline Carcinoma) – Drugs In Development, 2024 report and make more profitable business decisions. Nuclear protein in testis (NUT) midline carcinoma (NMC) is a rare and aggressive cancer that can grow anywhere in the body. It is caused by rearrangement of the NUTM1 gene. Symptoms include fatigue, weight loss, a painless lump, pain, persistent cough, and shortness of breath. NMC is difficult to diagnose and treat. There...
-
Product Insights
Pediatric Cancer - Drugs In Development, 2024
Empower your strategies with our Pediatric Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Pediatric cancer types include leukemias, brain and other central nervous system (CNS) tumors, and lymphomas. Signs and symptoms include unexplained paleness and loss of energy, easy bruising or bleeding, limping, fever, and headaches. Diagnosis can be done by blood tests, biopsy, ultrasound, MRI, and PET-CT scan. Common treatments include surgery, chemotherapy, radiation therapy, immunotherapy, and stem cell transplant. The Pediatric Cancer drugs...
-
Product Insights
Acostic Neuroma (Auditory Nerve Tumor) - Drugs In Development, 2024
Empower your strategies with our Acostic Neuroma (Auditory Nerve Tumor) – Drugs In Development, 2024 report and make more profitable business decisions. Acostic neuroma or vestibular schwannoma is a noncancerous, usually slow growing tumor affecting balance and auditory nerves. It is of two types: sporadic unilateral acoustic neuroma and genetic, bilateral acoustic neuroma. Hearing loss, dizziness, tinnitus, eye fullness, balance problems and vertigo, numbness in the face, and swallowing problems are some of the signs and symptoms. It can be diagnosed...
-
Product Insights
Choriocarcinoma (Gestational Trophoblastic Neoplasia) - Drugs In Development, 2024
Empower your strategies with our Choriocarcinoma (Gestational Trophoblastic Neoplasia) – Drugs In Development, 2024 report and make more profitable business decisions. Gestational trophoblastic disease (GTD) is a group of rare tumors that develop during the early stages of pregnancy. Most GTD tumors are benign (noncancerous), but some may turn into malignant (cancerous). GTD is categorized into hydatidiform moles and gestational trophoblastic neoplasia (GTN). Risk factors include age younger than 20 or older than 35, previous molar pregnancy, and history of miscarriage....
-
Product Insights
Clear Cell Squamous Cell Carcinoma - Drugs In Development, 2024
Empower your strategies with our Clear Cell Squamous Cell Carcinoma – Drugs In Development, 2024 report and make more profitable business decisions. Clear cell squamous cell carcinoma (SCC), or hydropic SCC, is an extremely rare variant of SCC. It may be caused by ultraviolet radiation. It is usually not life-threatening, but if left untreated, it can grow large or spread to other parts of the body. Symptoms include a rough, reddish, scaly area; a dome-shaped or wart-like growth; a new...
-
Product Insights
Colorectal Tumor - Drugs In Development, 2024
Empower your strategies with our Colorectal Tumor – Drugs In Development, 2024 report and make more profitable business decisions. Colorectal cancer, or colon cancer, is a disease where cells in the colon or rectum grow out of control. Most colorectal cancers start as polyps, which are growths on the inner lining of the colon or rectum. Risk factors for colorectal cancer include increased age. Symptoms include change in bowel habits, rectal bleeding or blood in the stool, abdominal discomfort, weakness, and...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.